Clinical Trial Update: A Study of Allogeneic Low Oxygen Mesenchymal Bone Marrow Cells in Subjects With Myocardial Infarction [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating allogeneic low-oxygen conditioned mesenchymal bone marrow cells in patients with myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Allogeneic Low Oxygen Mesenchymal Bone Marrow Cells

Snippet

Sponsor: Altaco XXI, LLP | Conditions: Myocardial Infarction | Phase 3 | Status: COMPLETED